Cancer And Venous Access (CAVA) ? A randomised controlled trial with associated qualitative research of venous access devices for the delivery of long-term chemotherapy

HS Greater Glasgow and Clyde (UK)0 个研究点目标入组 1,061 人开始时间: 2013年3月26日最近更新: 2022年8月15日

适应症

试验速览

2019 Results article in https://pubmed.ncbi.nlm.nih.gov/31292176/ patient acceptability qualitative results (added 04/08/2020) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34297997/ results (added 27/07/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34318743/ (added 29/07/2021)

•1. Aged = 18 years
•2. Receiving or to receive chemotherapy
•3.Duration of chemotherapy = 12 weeks
•4. Clinical team uncertain as to which device is optimal for this indication
•5. Solid or haematological malignancy
•6. Suitable upper extremity vein for all the access devices to which the patient may be randomised
•7. Able to provide written informed consent

•1. Life or treatment expectancy <3 months
•2.Previous venous access device removed due to complication within last three months
•3. Requirement for high volume (apheresis) line
•4. Need for catheter to be placed in a non upper extremity vein
•5. Patient previously randomised into the CAVA tria

发起方

HS Greater Glasgow and Clyde (UK)